Drug profile · INN
tadalafil
ADCIRCA
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
tadalafil (ADCIRCA) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN tadalafil
Brand ADCIRCA
Route ORAL
Formulation SUSPENSION
ATC code G04BE08
Originator Alphapharm Pty Ltd
Related patents
Search patents →Frequently asked questions
What is tadalafil?
tadalafil (ADCIRCA) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tadalafil?
ADCIRCA is a marketed brand name for tadalafil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tadalafil?
tadalafil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.